Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
659
-
Total 13F shares, excl. options
-
66.1M
-
Shares change
-
-1.65M
-
Total reported value, excl. options
-
$27.9B
-
Value change
-
-$686M
-
Put/Call ratio
-
1.25
-
Number of buys
-
319
-
Number of sells
-
-282
-
Price
-
$424.54
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2021
740 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q3 2021.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 659 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.1M shares
of 71.9M outstanding shares and own 91.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.53M shares), BlackRock Inc. (7.43M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.09M shares), STATE STREET CORP (3.4M shares), FRANKLIN RESOURCES INC (2.98M shares), APG Asset Management N.V. (2.54M shares), WCM INVESTMENT MANAGEMENT, LLC (1.44M shares), FMR LLC (1.37M shares), GEODE CAPITAL MANAGEMENT, LLC (1.34M shares), and Invesco Ltd. (1.26M shares).
This table shows the top 659 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.